Interim report
Page 1
Financial Statements for the 1st Quarter of the Fiscal Year Ending December 31 , 2021 KOBAYASHI PHARMACEUTICAL CO . , LTD . Summary of Financial Statements ( Japanese GAAP ) ( Consolidated ) Financial Results for the 1st Quarter of the Fiscal Year Ending December 31 , 2021 April 27 , 2021 : Tokyo : Kobayashi Pharmaceutical Co. , Ltd. : 4967 Listed exchanges Listed company name Code URL Representative officer Contact Tel : https://www.kobayashi.co.jp/english/index.html_ : Akihiro Kobayashi , President & COO : Satoshi Yamane , Senior Executive Director & Senior General Manager , Corporate Headquarters Expected date for submitting quarterly securities report Expected date for starting payment of dividends Preparation of supplementary documents for quarterly financial results : Yes Holding of an analyst meeting for quarterly financial results : + 81-6-6222-0142 Net sales : Yes ( For analysts and investors ) ( Any fraction less than 1 million yen is rounded down to the nearest million yen . ) 1. Consolidated Results for 1st Quarter of Fiscal Year Ending December 31 , 2021 ( January 1 , 2021 to March 31 , 2021 ) ( 1 ) Consolidated Operating Results ( accumulation ) Operating income Ordinary income Net income attributable to owners of the parent Net income per share ( Note ) Comprehensive income Q1 of FY ending December 31 , 2021 30,269 millions ( 5.1 ) % of yen 4,689 ( 3.8 ) 5,192 ( 2 ) Consolidated Financial Position 3,628 46.42 yen ( % figures represent changes from same period in previous year ) Q1 of FY ended December 31 , 2020 31,911 millions 0.7 % of yen Q1 of FY ending December 31 , 2021 : 6,787 million yen ( 652.9 % ) Q1 of FY ended December 31 , 2020 : 901 million yen ( -81.9 % ) 79.5 % : May 13 , 2021 3.0 ( 3.1 ) Q1 of FY ending December 31 , 2021 233,975 millions of yen 186,010 0-1 4,875 5,042 3,742 47.89 yen Total assets Net assets Shareholders ' equity ratio ( Reference ) Shareholders ' equity Q1 of FY ending December 31 , 2021 : 186,010 million yen FY ended December 31 , 2020 : 182,583 million yen ( 5.3 ) ( 3.4 ) 1.6 FY ended December 31 , 2020 238,366 millions of yen 182,583 76.6 %